DIRS.INFO The most relevant business & tech news

☆ How Amazon's cloud unit is helping researchers analyze genetics
▼ + stars: | 2022-12-28 | by ( Ashley Capoot | ) www.cnbc.com time to read: +6 min

Amazon Web Services recently launched general availability for Amazon Omics, which helps researchers store and analyze omic data like sequences of DNA, RNA and proteins. Amazon Omics helps researchers sort through their data by providing them with three components that they can leverage individually or as a collective. More than a dozen customers and partners tested a beta version of the service and are already using Amazon Omics. He said the department spent five years expanding the infrastructure to analyze omics data, and now it's no longer something they need to build or maintain themselves. C2i is a biotechnology company that's working to use genomic data to develop personalized treatments for cancer.

☆ U.S. weighs new measures for travelers from China as Japan says it will require negative Covid tests
▼ + stars: | 2022-12-28 | by ( Jihye Lee | ) www.cnbc.com time to read: +1 min

For more than two years, overseas travelers have had to quarantine upon arrival in China because of Covid restrictions. The U.S. government is considering imposing new Covid rules for travelers from China, officials said, citing concerns over virus-related data released by the Chinese government. The officials pointed to Japan's recent measures which require a negative Covid test for travelers arriving from mainland China from Dec. 30 – as China faces a sharp surge in infections nationwide following an abrupt reopening. Travelers from China without a valid vaccination certificate will also be required to take a pre-departure test, the notice from Japan's health ministry added. The measures will not apply to those traveling from Hong Kong and Macao, according to the notice.

☆ U.S. weighs new COVID rules for travelers from China, U.S. officials say
▼ + stars: | 2022-12-28 | by ( ) www.reuters.com time to read: +1 min

Dec 27 (Reuters) - The U.S. government may impose new COVID-19 measures on travelers to the United States from China over concerns about the "lack of transparent data" coming from Beijing, U.S. officials said on Tuesday. The move comes after Japan, India and Malaysia announced stepped up rules on travelers from China in the last 24 hours, citing a rise in infections there. Japan has said it would require a negative COVID-19 test upon arrival for travelers from the China. Some hospitals and funeral homes in China have been overwhelmed as the virus spreads largely unchecked across the country of 1.4 billion people. Official statistics, however, showed only one COVID death in the seven days to Monday, fuelling doubts among health experts and residents about the government's data.

☆ U.S. to impose mandatory COVID-19 tests for travelers from China
▼ + stars: | 2022-12-28 | by ( Julie Steenhuysen | ) www.reuters.com time to read: +4 min

CHICAGO, Dec 28 (Reuters) - The United States will impose mandatory COVID-19 tests on travelers from China, U.S. health officials said on Wednesday, joining India, Italy, Japan and Taiwan in taking new measures after Beijing's decision to lift stringent zero-COVID policies. The United States also is expanding its voluntary genomic sequencing program at airports, adding Seattle and Los Angeles to the program. Beijing has faced international criticism that its official COVID data and its tally of deaths are inconsistent with the scale of its outbreak. In June, the United States rescinded a 17-month-old requirement that people arriving in the country by air test negative for COVID-19. It still requires most non-U.S. citizens to be vaccinated against COVID to travel to the United States.

☆ Chinese hospitals 'extremely busy' as COVID spreads unchecked
▼ + stars: | 2022-12-28 | by ( Martin Quin Pollard | ) www.reuters.com time to read: +5 min

Staff at Huaxi, a big hospital in the southwestern city of Chengdu, said they were extremely busy caring for patients with COVID, as they have been ever since curbs were eased on Dec. 7. There were long queues inside and outside the hospital’s emergency department and at an adjacent fever clinic on Tuesday evening. “Almost all of the patients have COVID,” one emergency department pharmacy staff member said. Zhang Yuhua, an official at the Beijing Chaoyang Hospital, said most recent patients were elderly and critically ill with underlying diseases. She said the number of patients receiving emergency care had increased to 450-550 per day, from about 100 before, according to state media.

☆ A nutritionist shares the best snacks to bring on a plane to boost your immune system
▼ + stars: | 2022-12-26 | by ( Monica Pitrelli | ) www.cnbc.com time to read: +5 min

But there are steps people can take to reduce their chances of getting sick, say health specialists at Spain's SHA Wellness Clinic. Source: SHA Wellness ClinicEating a nutrient-dense diet is the top recommendation from Melanie Waxman, an integrative nutrition specialist and eating coach at SHA Wellness Clinic. Nori is alkaline and provides a good source of vitamin C, as well as omega-3 fatty acids, protein and minerals." Nori is alkaline and provides a good source of vitamin C, as well as omega-3 fatty acids, protein and minerals." Supplements, for someStudies indicate that certain supplements — such as vitamin C, vitamin D, zinc, garlic, echinacea and green tea — may strengthen the body's immune response, Mera said.

"The jury is still out," on which technology will dominate, said Dr. Sadik Esener, director of the Cancer Early Detection Advanced Research Center at the OHSU Knight Cancer Institute in Portland, Oregon. He added it could take as long as 20 years to show that an early cancer detection test saved lives. If proven to work, early cancer detection tests could help doctors identify cancer risk in patients long before symptoms or other indicators develop. DIFFERENT APPROACHESSeveral of the leading contenders take vastly different approaches to cancer detection and it is not yet clear which methods will prove most useful or when. Some are working on blood tests to detect different markers of early cancer, including proteins.

☆ A Silicon Valley biotech just showed a simple blood test can detect a hidden and deadly type of cancer. But the results fell short of investors' hopes.
▼ + stars: | 2022-12-15 | by ( Leah Rosenbaum | ) www.businessinsider.com time to read: +7 min

Guardant Health said that its blood test to screen for cancer caught 83% of colorectal cancer cases. On Thursday, Silicon Valley-based biotech Guardant Health announced that its blood-based cancer screening test correctly caught colorectal cancer cases in 83% of people who had the disease. The company already has several products on the market, including Guardant360CDx, an FDA-approved blood test to test cancer genomic markers that could help show what treatments the cancers are susceptible to. Colonoscopies are still the gold standard of colorectal cancer screening, despite involving sedation and hours of unpleasant physical preparation. And while colorectal cancer is the first cancer that is being studied for a blood-based screening, it certainly won't be the last.

☆ Amazon unveils supply-chain, cloud services drawing on its retail arm
▼ + stars: | 2022-11-29 | by ( Jeffrey Dastin | ) www.reuters.com time to read: +1 min

At its annual Las Vegas conference, the cloud unit also showed off AWS Clean Rooms, which allows businesses to tailor ads to customers while maintaining their privacy, among other applications. The services are part of Amazon's long-time strategy to develop functions for its e-commerce arm and then offer them to other companies. At the same time, Amazon's cloud has lost out on sales to brick-and-mortar retailers which are reluctant to hire a company that is also their e-commerce competitor. Other new services it announced include Amazon Omics for genomic analysis and Amazon Security Lake, which helps businesses assemble data from cybersecurity vendors and other sources. Reporting by Jeffrey Dastin in Las Vegas; Editing by Richard ChangOur Standards: The Thomson Reuters Trust Principles.

☆ Billionaires like Elon Musk want to save civilization by having tons of genetically superior kids. Inside the movement to take 'control of human evolution.'
▼ + stars: | 2022-11-17 | by ( Julia Black | ) www.businessinsider.com time to read: +40 min

"We are the Underground Railroad of 'Gattaca' babies and people who want to do genetic stuff with their kids," Malcolm told me. Ellison, meanwhile, who has two children in their 30s, has reportedly resumed having kids — with his 31-year-old girlfriend. "The person of this subculture really sees the pathway to immortality as being through having children," Simone said. The person of this subculture really sees the pathway to immortality as being through having children. Before she met Malcolm, Simone was convinced she wanted to live her life single and child-free.

☆ Man who had COVID-19 for 400 days finally cured after getting treated with antibodies, study says
▼ + stars: | 2022-11-16 | by ( Marianne Guenot | ) www.businessinsider.com time to read: +3 min

A man carried COVID-19 for more than 400 days. The patient was paucisymptomatic, meaning he did not have the symptoms typical of COVID-19, like cough, fever, or loss of smell. But doctors finally managed to cure the patient by giving him anti-COVID-19 antibodies in February 2022. Though the patient's case is characteristically long, it is not the longest-ever reported infection for COVID-19. In another case, reported in June 2021, the virus mutated more than 30 times in a patient whose immune system was weakened by HIV.

☆ High-performance computing saves the day
▼ + stars: | 2022-11-14 | by ( Sponsor Post | Sponsored Microsoft Azure | ) www.businessinsider.com time to read: +4 min

Whether there's a cyberattack or a heart attack, Microsoft Azure's high-performance computing solutions and Intel's processing speed empower Dataville's citizens to thwart danger, protect themselves, and innovate to create a better city. Dataville makes sustainable changesWhen Dataville senses that one unscrupulous factory in town is polluting the air, it's able to act quickly. Dataville provides better healthcareWhen Dataville citizens have a health crisis, healthcare providers can save the day. See how Microsoft Azure and Intel can give you superpowers. This post was created by Insider Studios with Microsoft Azure and Intel.

☆ A healthcare startup that wants to offer personalized treatments for depression just used this presentation to raise $14 million
▼ + stars: | 2022-10-31 | by ( Yeji Jesse Lee | ) www.businessinsider.com time to read: +2 min

The German biotech company HMNC believes there's a better way to approach depression. It just raised $14 million from investors to follow through on its strategy. The German biotech company HMNC Brain Health is looking to do something similar in psychiatry. Maximilian Döbler is the chief business officer of HMNC Brain Health. See the presentation HMNC Brain Health used to raise $14 million:

☆ See the 12-slide pitch deck a mental-health startup founded by a German billionaire used to raise $14 million to develop more precise treatments for depression
▼ + stars: | 2022-10-25 | by ( Yeji Jesse Lee | ) www.businessinsider.com time to read: +1 min

People with depression often go through trial and error to find treatments that work best for them. The German biotech company HMNC believes there's a better way to approach depression. It just raised $14 million from investors to follow through on its strategy. The German biotech company HMNC Brain Health is looking to do something similar in psychiatry. See the presentation HMNC Brain Health used to raise $14 million:

☆ In internal meetings and leaked documents, Amazon dreams of taking on Google's DeepMind by using machine learning to revolutionize drug discovery, genomics, clinical trials and more
▼ + stars: | 2022-10-21 | by ( Eugene Kim | ) www.businessinsider.com time to read: +7 min

Amazon held an internal machine learning conference last week. The deployment of machine learning across healthcare was a major topic. The event was all about machine learning, a powerful type of artificial intelligence that has already transformed Amazon's business and those of other tech giants. He was joined at last week's Amazon Machine Learning Conference by Amazon's chief medical officer Taha Kass-Hout. One of the workshops was about machine learning for "human health."

☆ 2 takeaways from our daily meeting: Semiconductors, Danaher's earnings beat
▼ + stars: | 2022-10-20 | by ( Krystal Hur | ) www.cnbc.com time to read: +3 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Sticking with our semiconductor strategy Semiconductor stocks climbed Thursday on the back of earnings beats from International Business Machines Corp. (IBM) and Lam Research (LRCX), with the broader market also rallying. Regardless, we don't regret our decision to trim our semiconductor stocks earlier this month. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

☆ Prime Medicine dipped 10% in its public debut. We dug through the biotech's 283-page filing to find 5 key takeaways about the company's plan to commercialize gene editing.
▼ + stars: | 2022-10-20 | by ( Andrew Dunn | ) www.businessinsider.com time to read: +8 min

The gene-editing biotech Prime Medicine went public on Thursday. From a key patent to an uncertain timeline, here are five takeaways from Prime's filing. Its goal is to advance prime editing, a twist on CRISPR gene editing that could allow for a wider range of edits to DNA. Prime editing, another version of next-generation gene editing, works like a word processor, "searching for the correct location and replacing or repairing a wide variety of target DNA," the filing said. Jessica Rinaldi/The Boston Globe via Getty ImagesDavid Liu, a Harvard gene-editing scientist who co-invented base editing and prime editing, is Prime's largest shareholder.

☆ Biden Administration Pares Back Covid Fight as Funding Push Falls Short
▼ + stars: | 2022-10-18 | by ( Stephanie Armour | ) www.wsj.com time to read: 1 min

The Biden administration has stopped paying to mail out free Covid-19 tests and expects to end free vaccines for Americans after Congress dropped billions of dollars for such efforts from a government funding bill last month. People familiar with the matter said the administration’s Covid-19 task force will remain in place ahead of an expected uptick in cases in the coming winter months. But the team will shift focus from emergency response to longer-term issues, such as boosting domestic manufacturing of personal protective equipment, researching long Covid and supporting genomic sequencing to identify variants, the people said.

☆ Cathie Wood says this emerging investing trend is the 'most misunderstood and underappreciated'
▼ + stars: | 2022-10-13 | by ( Yun Li | ) www.cnbc.com time to read: +1 min

Ark Invest's Cathie Wood believes innovators in DNA development are the most undervalued corner of the market. "I believe that today the genomic revolution is most misunderstood and underappreciated," Wood said at Morgan Stanley's AlphaCurrents Conference last week, according to a transcript provided by the bank. "The stocks in the last year, this growth stock bear market, has ravaged the genomic space. Ark Invest has a specific exchange-traded fund dedicated to this space: ARK Genomic Revolution ETF (ARKG) . However, the fund has wiped out half of its value this year as rising rates hit growth stocks particularly hard.

☆ Prime Medicine is gearing up for a $200 million IPO. We dug through the biotech's 282-page filing to find 5 key takeaways about the company's plan to commercialize gene editing.
▼ + stars: | 2022-09-28 | by ( Andrew Dunn | ) www.businessinsider.com time to read: +8 min

From an uncertain timeline to the clinic to a key patent, here are 5 takeaways from Prime's filing. The company's goal is to advance prime editing, a twist on CRISPR gene editing that could allow for a wider range of edits to DNA. Prime editing is another version of next-generation gene editing. Prime's filing comes in a difficult market for biotechs, but particularly for companies that have yet to start human testing. Jessica Rinaldi/The Boston Globe via Getty ImagesDavid Liu, a Harvard gene-editing scientist who co-invented base editing and prime editing, is currently Prime's largest shareholder.

☆ Alarmant: Varianta indiană a coronavirusului este cu 50% mai contagioasă decât cea britanică
▼ + stars: | 2021-06-08 | by ( Publika.Md - Aici Sunt Știrile | ) www.publika.md time to read: +2 min

Varianta coronavirusului detectată în India (varianta Delta) este cu 50% mai contagioasă decât cea detectată în Marea Britanie (varianta Alfa) şi este responsabilă de raportarea a peste 400.000 de cazuri pe zi în această ţara asiatică, potrivit unui studiu preliminar realizat de guvernul indian. Într-una din regiunile Indiei, varianta Delta a înlocuit varianta Alfa, care avea prevalenţă de aproape 100%. Potrivit studiului, varianta Delta are un grad înalt de transmisibilitate care este cu până la 50% mai mare decât B.1.1.7, varianta Alfa detectată pentru prima oară în Marea Britanie, ca urmare a unei încărcături virale mai mari şi o capacitate mai mare de penetrare a sistemului imunitar. Înalta transmisibilitate a variantei Delta s-a impus şi în statul de nord Punjab, unde varianta la B.1.1.7, care avea o prevalenţă de aproape 100% în această regiune a fost înlocuită treptat cu tulpina B.1.617.2. Curba epidemică a intrat însă pe o pantă descendentă în India, care a luni a raportat sub 100.000 de contagieri şi 2.400 de decese, cele mai scăzute cifre raportate în ultimele două luni.

Persons: ., 1.617.2 Organizations: Alfa, National Centre, Agerpres Locations: India, Indiei, Punjab

☆ Studiu: Varianta indiană a coronavirusului este cu 50% mai contagioasă decât cea britanică
▼ + stars: | 2021-06-07 | by ( ) www.jurnal.md time to read: +2 min

Sursa foto: time.comStudiu: Varianta indiană a coronavirusului este cu 50% mai contagioasă decât cea britanicăVarianta coronavirusului detectată în India (varianta Delta) este cu 50% mai contagioasă decât cea detectată în Marea Britanie (varianta Alfa) şi este responsabilă de raportarea a peste 400.000 de cazuri pe zi în această ţara asiatică, potrivit unui studiu preliminar realizat de guvernul indian. Într-una din regiunile Indiei, varianta Delta a înlocuit varianta Alfa, care avea prevalenţă de aproape 100%. Potrivit studiului, varianta Delta are un grad înalt de transmisibilitate care este cu până la 50% mai mare decât varianta Alfa detectată pentru prima oară în Marea Britanie, ca urmare a unei încărcături virale mai mari şi o capacitate mai mare de penetrare a sistemului imunitar. Deşi datele sugerează că o creştere timpurile a cazurilor a avut loc între ianuarie şi februarie. Înalta transmisibilitate a variantei Delta s-a impus şi în statul de nord Punjab, unde varianta la B.1.1.7, care avea o prevalenţă de aproape 100% în această regiune a fost înlocuită treptat cu tulpina B.1.617.2.

Persons: 1.617.2 Organizations: Alfa, National Centre Locations: India, Indiei, Punjab

Search resuls for: "Genomic"

22 mentions found